Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography imaging. (2006)
Attributed to:
Molecular Therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.CAN-06-1539
PubMed Identifier: 16982761
Publication URI: http://europepmc.org/abstract/MED/16982761
Type: Journal Article/Review
Volume: 66
Parent Publication: Cancer research
Issue: 18
ISSN: 0008-5472